-
A newly published series of reports calls attention to a dire situation facing millions of women after childbirth — and the solutions that can prevent death from postpartum hemorrhage.
-
It’s a condition that affects about 27 million women each year.
-
Daraxonrasib is an experimental pill that doubled survival time compared to standard chemotherapy, according to the results of a clinical trial.
-
Spending too much time and money on skin care? Find out what really works to improve skin health and appearance with our one-week newsletter guide. Sign up here.
-
Trump's Department of Justice is seeking patient files that include the names of young people who have been treated in transgender clinics, as well as hospital staff who have provided care.
-
The DRC has improved testing capacity for Ebola with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.
-
A study of more than 2,300 9- to 10-year-olds found that socioeconomic factors explained most differences in the preteens' brain development.
-
The administration imposed mandatory quarantine orders on two passengers from the cruise ship hit by hantavirus and is blocking Americans who catch Ebola from returning home for treatment.
-
Clinical psychologist Riana Elyse Anderson explains how factors like high digital engagement, exposure to online harm, and broader social stressors intersect to influence mental health outcomes.
-
The FDA approved a new sunscreen ingredient for the U.S. Bemotrizinol has long been used in Europe and Asia. The chemical compound protects against UVA and UVB rays.
-
The Trump administration has imposed tough restrictions in response to hantavirus and Ebola, including quarantine orders and travel bans. That's despite past criticism of many COVID measures.
-
APRNs — advanced practice registered nurses — help provide access to health care especially in areas where there may be a shortage. Strict regulations in some states prompt many to cross state lines.